Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.59B -16.9%
Revenue (ttm)	569.57M -4.3%
Net Income	98.23M +15.1%
EPS	1.94 +3.2%
Shares Out	45.38M
PE Ratio	29.38
Forward PE	n/a
Dividend	1.05 (1.84%)
Ex-Dividend Date	Jun 26, 2025

Volume	63,627
Open	56.50
Previous Close	56.50
Day's Range	56.00 - 57.00
52-Week Range	50.60 - 80.40
Beta	-0.06
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 172
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2025, TPEX:4747's revenue was 569.77 million, a decrease of -6.81% compared to the previous year's 611.42 million. Earnings were 53.51 million, a decrease of -36.40%.